Psychological determinants of drug adherence and severity of hypertension in patients with apparently treatment-resistant vs. controlled hypertension

被引:6
|
作者
Georges, Coralie M. G. [1 ]
Ritscher, Sabrina [2 ]
Pappaccogli, Marco [3 ]
Petit, Geraldine [4 ,5 ]
Lopez-Sublet, Marilucy [1 ,6 ]
Bapolisi, Achille [4 ,5 ,7 ,8 ]
Di Monaco, Silvia [3 ]
Wallemacq, Pierre [9 ,10 ]
Rabbia, Franco [3 ]
Toennes, Stefan W. [2 ]
de Timary, Philippe [4 ,5 ]
Persu, Alexandre [1 ,11 ]
机构
[1] Catholic Univ Louvain, Clin Univ St Luc, Dept Cardiol, Brussels, Belgium
[2] Goethe Univ Frankfurt, Univ Hosp Frankfurt, Inst Legal Med, Dept Forens Toxicol, Frankfurt, Germany
[3] AOU Citta Salute & Sci, Dept Med Sci, Internal Med & Hypertens Div, Turin, Italy
[4] Catholic Univ Louvain, Clin Univ St Luc, Adult Psychiat Dept, Brussels, Belgium
[5] Catholic Univ Louvain, Clin Univ St Luc, Inst Neurosci, Brussels, Belgium
[6] CHU Avicenne AP HP, ESH Hypertens Excellence Ctr, Dept Internal Med, Bobigny, France
[7] Univ Catholique Bukavu, Bukavu, DEM REP CONGO
[8] Hop Prov Gen Bukavu, Bukavu, DEM REP CONGO
[9] Clin Univ St Luc, Clin Chem Dept, Brussels, Belgium
[10] Catholic Univ Louvain, Ctr Toxicol & Appl Pharmacol, Brussels, Belgium
[11] Catholic Univ Louvain, Inst Rech Expt & Clin, Pole Cardiovasc Res, Brussels, Belgium
关键词
Resistant hypertension; drug adherence; psychological profile; expression of emotions; somatisation; EMOTION REGULATION; SOMATIZATION; ALEXITHYMIA; VALIDATION; MEDICATION;
D O I
10.1080/08037051.2022.2099346
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Purpose In a pilot study including 35 patients with apparently treatment-resistant hypertension (ATRH), we documented associations between psychological profile, drug adherence and severity of hypertension. The current study aims to confirm and expand our findings in a larger and more representative sample of patients with ATRH, using controlled hypertensive patients as the comparator. Materials and Methods Patients with ATRH were enrolled in hypertension centres from Brussels and Torino. The psychological profile was assessed using five validated questionnaires. Drug adherence was assessed by high-performance liquid chromatography-tandem mass spectrometry analysis of urine samples, and drug resistance by 24-hour ambulatory blood pressure was adjusted for drug adherence. Results The study sample totalised 144 patients, including 81 ATRH and 63 controlled hypertensive patients. The mean adherence level was significantly lower in the "resistant" group (78.9% versus 92.7% in controlled patients, p-value = .022). In patients with ATRH, independent predictors of poor drug adherence were somatisation, smoking and low acceptance level of difficult situations, accounting for 41% of the variability in drug adherence. Independent predictors of severity of hypertension were somatisation, smoking, more frequent admissions to the emergency department and low acceptation, accounting for 63% of the variability in the severity of hypertension. In contrast, in patients with controlled hypertension, the single predictors of either drug adherence or severity of hypertension were the number of years of hypertension and, for the severity of hypertension, alcohol consumption, accounting for only 15-20% of the variability. Conclusion Psychological factors, mostly related to somatisation and expression of emotions are strong, independent predictors of both drug adherence and severity of hypertension in ATRH but not in controlled hypertensive patients. Plain language summary This study included 144 patients with Apparently-Treatment Resistant (ATRH) or controlled Hypertension: Patients with ATRH were more often poorly adherent to antihypertensive treatment than controlled hypertensive patients. In patients with ARTH but not patients with controlled hypertension, psychological traits were strong, independent predictors of drug adherence and severity of hypertension, over and above demographic and health-related factors. In patients with ATRH, the tendency to somatize, i.e. expressing somatic symptoms that cannot be adequately explained by organic findings was the most potent predictor of both poor drug adherence and severity of hypertension. These patients also often presented alterations in the expression of emotions. It may be hypothesised that subjects who have difficulties identifying and expressing emotions with words will express them by physical complaints, and, in the mid-long term, might develop overt diseases. In addition to more classical lifestyle and drug management and irrespective of their drug adherence level, patients with ATRH may benefit in priority from psychological evaluation and interventions. However, this needs to be studied in an interventional trial in the future.
引用
收藏
页码:169 / 177
页数:9
相关论文
共 50 条
  • [1] PSYCHOLOGICAL DETERMINANTS OF DRUG ADHERENCE AND SEVERITY OF HYPERTENSION IN PATIENTS WITH RESISTANT VS. CONTROLLED HYPERTENSION
    Persu, Alexandre
    Georges, Coralie M. G.
    Ritscher, Sabrina
    Pappaccogli, Marco
    Petit, Geraldine
    Lopez-Sublet, Marilucy
    Bapolisi, Achille
    Di Monaco, Silvia
    Wallemacq, Pierre
    Rabbia, Franco
    Toennes, Stefan W.
    De Timary, Philippe
    JOURNAL OF HYPERTENSION, 2022, 40 (SUPPL) : E55 - E55
  • [2] ASSESSMENT OF DRUG ADHERENCE AND PSYCHOLOGICAL PROFILE IN PATIENTS WITH APPARENTLY TREATMENT-RESISTANT HYPERTENSION
    Georges, C.
    Berra, E.
    Capron, A.
    Petit, G.
    De Timary, P.
    Wallemacq, P.
    Persu, A.
    JOURNAL OF HYPERTENSION, 2017, 35 : E16 - E17
  • [3] Impact of psychological profile on drug adherence and drug resistance in patients with apparently treatment-resistant hypertension
    Petit, Geraldine
    Berra, Elena
    Georges, Coralie M. G.
    Capron, Arnaud
    Huang, Qi-Fang
    Lopez-Sublet, Marilucy
    Rabbia, Franco
    Staessen, Jan A.
    Wallemacq, Pierre
    de Timary, Philippe
    Persu, Alexandre
    BLOOD PRESSURE, 2018, 27 (06) : 358 - 367
  • [4] Drug adherence and psychological factors in patients with apparently treatment-resistant hypertension: Yes but which ones?
    Georges, Coralie M. G.
    Pappaccogli, Marco
    Fanelli, Elvira
    Petit, Geraldine
    Ritscher, Sabrina
    Lopez-Sublet, Marilucy
    Bapolisi, Achille
    Wallemacq, Pierre
    Rabbia, Franco
    de Timary, Philippe
    Toennes, Stefan W.
    Persu, Alexandre
    JOURNAL OF CLINICAL HYPERTENSION, 2022, 24 (11): : 1436 - 1443
  • [5] Adherence to antihypertensive drug treatment in patients with apparently treatment-resistant hypertension in the INSPiRED pilot study
    Wunder, Cora
    Persu, Alexandre
    Lengele, Jean-Philippe
    Georges, Coralie M. G.
    Renkin, Jean
    Pasquet, Agnes
    Carlier, Marc
    Zhang, Zhen-Yu
    Staessen, Jan A.
    Toennes, Stefan W.
    BLOOD PRESSURE, 2019, 28 (03) : 168 - 172
  • [6] Evaluation of Adherence Should Become an Integral Part of Assessment of Patients With Apparently Treatment-Resistant Hypertension
    Berra, Elena
    Azizi, Michel
    Capron, Arnaud
    Hoieggen, Aud
    Rabbia, Franco
    Kjeldsen, Sverre E.
    Staessen, Jan A.
    Wallemacq, Pierre
    Persu, Alexandre
    HYPERTENSION, 2016, 68 (02) : 297 - +
  • [7] Adherence to medication and drug monitoring in apparent treatment-resistant hypertension
    Eskas, Per Anders
    Heimark, Sondre
    Mariampillai, Julian Eek
    Larstorp, Anne Cecilie K.
    Elmula, Fadl Elmula M. Fadl
    Hoieggen, Aud
    BLOOD PRESSURE, 2016, 25 (04) : 199 - 205
  • [8] Improving adherence with treatment-resistant hypertension
    Borghi, Claudio
    Cicero, Arrigo F. G.
    EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (11) : 1373 - 1375
  • [9] Prognosis of treatment-resistant hypertension by medication adherence
    Hatta, Tsuguru
    HYPERTENSION RESEARCH, 2025, 48 (03) : 1244 - 1245
  • [10] Emerging concepts for patients with treatment-resistant hypertension
    Eirin, Alfonso
    Textor, Stephen C.
    Lerman, Lilach O.
    TRENDS IN CARDIOVASCULAR MEDICINE, 2016, 26 (08) : 700 - 706